Moran Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.41M | Sell |
4,590
-15,211
| -77% | -$7.99M | 0.07% | 266 |
|
|
2025
Q1 | $12.6M | Buy |
19,801
+123
| +0.6% | +$78K | 0.42% | 78 |
|
|
2024
Q4 | $14M | Sell |
19,678
-2,538
| -11% | -$1.81M | 0.45% | 80 |
|
|
2024
Q3 | $23.4M | Buy |
22,216
+2,572
| +13% | +$2.7M | 0.72% | 36 |
|
|
2024
Q2 | $20.6M | Sell |
19,644
-450
| -2% | -$473K | 0.68% | 39 |
|
|
2024
Q1 | $19.3M | Sell |
20,094
-427
| -2% | -$411K | 0.63% | 47 |
|
|
2023
Q4 | $18M | Sell |
20,521
-7
| -0% | -$6.15K | 0.64% | 44 |
|
|
2023
Q3 | $16.9M | Sell |
20,528
-312
| -1% | -$257K | 0.65% | 47 |
|
|
2023
Q2 | $15M | Sell |
20,840
-745
| -3% | -$535K | 0.56% | 66 |
|
|
2023
Q1 | $17.7M | Sell |
21,585
-401
| -2% | -$329K | 0.67% | 48 |
|
|
2022
Q4 | $15.9M | Buy |
+21,986
| New | +$15.9M | 0.6% | 49 |
|